The Life Sciences Report

Experience, Creativity And Dedication To Finding And Presenting The Best Investment Ideas

Contributor's Links: The Life Sciences Report

The Life Sciences Report features leading investment coverage of the life sciences sector, including biotechnology, pharmaceuticals, tools & diagnostics, and medical devices. A Streetwise Reports publication.

The Streetwise Reports Team combines experience, creativity and ... more

Following: 17 Followers: 2715

ALL CONTRIBUTIONS

MRI Device Maker's Earnings Come In At High End Of Forecasts

Wednesday, August 3, 2022 12:19 PM EST

After its earnings beat, improved margins and disciplined cost control measures, IRadimed keeps its buy rating and its price target has been raised to $42/share (up from $40).

In this article: IRMD

Read

HC Staffing Firm Posts Triple-Digit Revenue Gains In Q421

Saturday, February 19, 2022 8:45 PM EST

AMN Healthcare Services traded 12% higher after the company reported Q4/21 financial results that included a 116% YoY increase in revenue and a 1,149% YoY increase in net income.

In this article: AMN

Read

Inotiv Makes $545 Million Bid For Envigo RMS Holdings To Fortify Research And Drug Discovery Platforms

Tuesday, September 21, 2021 6:03 PM EST

Shares of Inotiv Inc. traded 27% higher to a new 52-week high after the company reported it entered into an agreement to acquire Envigo RMS Holding Corp. in a cash and stock deal valued at $545 million.

In this article: NOTV

Read

Oil Breaking Out, But The Money Is Elsewhere

Monday, October 9, 2017 11:07 PM EST

One resource industry dwarfs the rest of them put together: energy.

Read

Immunotherapy Company's Q2 Revenue 'Handily Beats' H.C. Wainwright's Projection

Thursday, August 17, 2017 1:17 PM EST

Inovio Pharmaceuticals Inc. exited Q2/17 with $92 million in cash. It has closed a public offering that yielded $70.5 million, which "would be used for general corporate purposes, including clinical trial expenses.

In this article: INO

Read

HIV Vaccine Clinical Study Results In High Immune Response Rates In Healthy Subjects

Wednesday, June 7, 2017 12:01 PM EST

A clinical study of an HIV vaccine in healthy subjects that found a nearly 100% immune response rate was hailed by a pair of industry analysts. Inovio Pharmaceuticals Inc. has a "buy" rating.

In this article: INO Also: GILD

Read

Comments

ABBV	AbbVie Inc.
ABT	Abbott Laboratories
ACAD	ACADIA Pharmaceuticals Inc.
ACFN	Acorn Energy Inc.
ACHN	Achillion Pharmaceuticals Inc.
ACOR	Acorda Therapeutics, Inc.
ACRX	AcelRx Pharmaceuticals Inc.
ACTC	ADVANCED CELL TECH
ADDXF	ADDEX PHARMA ORD
ALPMF	ASTELLAS PHARMA INC
AMBS	Amarantus Bioscience Holdings Inc
APRI	Apricus Biosciences, Inc
ARIA	ARIAD Pharmaceuticals Inc.
ARNA	Arena Pharmaceuticals, Inc.

TWEETS

PERSONAL BLOG

Work Experience

Publications

Publication:	The Life Sciences Report
Author(s):	Streetwise Reports
Description:	Focused on biotechnology, pharmaceuticals, medical devices, tools and diagnostics.